항콕시듐제 시장(2026-2030년)

The global anticoccidial drugs market is forecasted to grow by USD 93219.2 thousand during 2025-2030, accelerating at a CAGR of 4.5% during the forecast period. The report on the global anticoccidial drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of parasitic infections in high-density livestock farming, expansion of veterinary healthcare infrastructure and institutional distribution, digital transformation and e-commerce integration in agricultural supply chains.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global anticoccidial drugs market is segmented as below:

By Drug Class

• Ionophore
• Chemical derivative

By Animal Type

• Poultry
• Livestock
• Companion animals

By Distribution Channel

• Veterinary hospitals and clinics
• Retail pharmacies
• Online pharmacies

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of phytogenic feed additives and botanical formulations as one of the prime reasons driving the global anticoccidial drugs market growth during the next few years. Also, advancement of molecular diagnostics and precision parasite monitoring systems and strategic mergers and portfolio diversification among global animal health enterprises will lead to sizable demand in the market.

The report on the global anticoccidial drugs market covers the following areas:

• Global anticoccidial drugs market sizing
• Global anticoccidial drugs market forecast
• Global anticoccidial drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global anticoccidial drugs market vendors that include AdvaCare Pharma, Ashish Life Science Pvt. Ltd., Bimeda Holdings Ltd., Biogenesis Bago SA, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma Group, ECO Animal Health Group plc, FATRO SpA, HIPRA SA, Huvepharma Inc, Intas Pharmaceuticals Ltd., Laboratorios Calier S.A., Laboratorios Maymo S.A., Merck and Co. Inc., Norbrook Laboratories Ltd., Ouro Fino Saude Animal Participacoes, Vets Farma Ltd, VH Group, Zenex Animal Health India Ltd., Zoetis Inc.. Also, the global anticoccidial drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Market Segmentation by Animal Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Anticoccidial Drugs Market 2020 - 2024
  • Historic Market Size - Data Table on Global Anticoccidial Drugs Market 2020 - 2024 ($ thousand)
• 5.2 Drug Class segment analysis 2020 - 2024
  • Historic Market Size - Drug Class Segment 2020 - 2024 ($ thousand)
• 5.3 Animal Type segment analysis 2020 - 2024
  • Historic Market Size - Animal Type Segment 2020 - 2024 ($ thousand)
• 5.4 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ thousand)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on global anticoccidial drugs market
• 6.2 Impact of geopolitical conflicts on global anticoccidial drugs market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Drug Class

• 8.1 Market segments
• 8.2 Comparison by Drug Class
• 8.3 Ionophore - Market size and forecast 2025-2030
• 8.4 Chemical derivative - Market size and forecast 2025-2030
• 8.5 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ thousand)

9 Market Segmentation by Animal Type

• 9.1 Market segments
• 9.2 Comparison by Animal Type
• 9.3 Poultry - Market size and forecast 2025-2030
• 9.4 Livestock - Market size and forecast 2025-2030
• 9.5 Companion animals - Market size and forecast 2025-2030
• 9.6 Market opportunity by Animal Type
  • Market opportunity by Animal Type ($ thousand)

10 Market Segmentation by Distribution Channel

• 10.1 Market segments
• 10.2 Comparison by Distribution Channel
• 10.3 Veterinary hospitals and clinics - Market size and forecast 2025-2030
• 10.4 Retail pharmacies - Market size and forecast 2025-2030
• 10.5 Online pharmacies - Market size and forecast 2025-2030
• 10.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ thousand)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of parasitic infections in high-density livestock farming
  • Expansion of veterinary healthcare infrastructure and institutional distribution
  • Digital transformation and e-commerce integration in agricultural supply chains
• 13.2 Market challenges
  • Escalating antimicrobial resistance and rotation fatigue across commercial livestock operations
  • Stringent regulatory restrictions on residue limits and antibiotic prophylaxis
  • Rapid market penetration of vaccine alternatives and antibiotic-free meat preferences
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of phytogenic feed additives and botanical formulations
  • Advancement of molecular diagnostics and precision parasite monitoring systems
  • Strategic mergers and portfolio diversification among global animal health enterprises

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AdvaCare Pharma
  • AdvaCare Pharma - Overview
  • AdvaCare Pharma - Product / Service
  • AdvaCare Pharma - Key offerings
  • SWOT
• 15.5 Bimeda Holdings Ltd.
  • Bimeda Holdings Ltd. - Overview
  • Bimeda Holdings Ltd. - Product / Service
  • Bimeda Holdings Ltd. - Key offerings
  • SWOT
• 15.6 Biogenesis Bago SA
  • Biogenesis Bago SA - Overview
  • Biogenesis Bago SA - Product / Service
  • Biogenesis Bago SA - Key offerings
  • SWOT
• 15.7 Boehringer Ingelheim GmbH
  • Boehringer Ingelheim GmbH - Overview
  • Boehringer Ingelheim GmbH - Product / Service
  • Boehringer Ingelheim GmbH - Key offerings
  • SWOT
• 15.8 Ceva Sante Animale
  • Ceva Sante Animale - Overview
  • Ceva Sante Animale - Product / Service
  • Ceva Sante Animale - Key offerings
  • SWOT
• 15.9 Chanelle Pharma Group
  • Chanelle Pharma Group - Overview
  • Chanelle Pharma Group - Product / Service
  • Chanelle Pharma Group - Key offerings
  • SWOT
• 15.10 FATRO SpA
  • FATRO SpA - Overview
  • FATRO SpA - Product / Service
  • FATRO SpA - Key offerings
  • SWOT
• 15.11 Intas Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd. - Overview
  • Intas Pharmaceuticals Ltd. - Product / Service
  • Intas Pharmaceuticals Ltd. - Key offerings
  • SWOT
• 15.12 Laboratorios Calier S.A.
  • Laboratorios Calier S.A. - Overview
  • Laboratorios Calier S.A. - Product / Service
  • Laboratorios Calier S.A. - Key offerings
  • SWOT
• 15.13 Laboratorios Maymo S.A.
  • Laboratorios Maymo S.A. - Overview
  • Laboratorios Maymo S.A. - Product / Service
  • Laboratorios Maymo S.A. - Key offerings
  • SWOT
• 15.14 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
  • SWOT
• 15.15 Norbrook Laboratories Ltd.
  • Norbrook Laboratories Ltd. - Overview
  • Norbrook Laboratories Ltd. - Product / Service
  • Norbrook Laboratories Ltd. - Key offerings
  • SWOT
• 15.16 VH Group
  • VH Group - Overview
  • VH Group - Product / Service
  • VH Group - Key offerings
  • SWOT
• 15.17 Zenex Animal Health India Ltd.
  • Zenex Animal Health India Ltd. - Overview
  • Zenex Animal Health India Ltd. - Product / Service
  • Zenex Animal Health India Ltd. - Key offerings
  • SWOT
• 15.18 Zoetis Inc.
  • Zoetis Inc. - Overview
  • Zoetis Inc. - Business segments
  • Zoetis Inc. - Key offerings
  • Zoetis Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations